Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ARCAGY/ GINECO GROUP
* to establish prognosis factors for the disease
* to proceed in a centralised examination of histologic laminas
* to reach in the long-term and homogenous follow-up of the patients
* to follow-up the long-term toxicities of the treatments given
* to analyse and follow-up the later fertility of the patients
* to evaluate the interest of setting a multi-disciplinary discussion forum on the Web
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
age \> 18 years old
germinal or sexual cords ovary tumors histologically proven
first line or relapse treatment
written informed consent
You may not be if
mental ineptitude to understand and follow the study
Clareo Health | French Observatory of Rare Malignant Tumors of the Ovary
